Frazier Healthcare Partners
Overview
Frazier Healthcare Partners is a private equity and venture capital firm founded in 1991 that focuses exclusively on the healthcare sector, including services, medical devices, pharmaceuticals, and biopharmaceuticals.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| pci pharma services | Aug 2020 | Buyout/LBO | Co-investor |
| MBX Biosciences | Jul 2020 | Series A | Lead |
| Aclaris Therapeutics | Aug 2015 | Series C | Co-investor |
| Radionetics Oncology | Oct 2021 | Seed | Lead |
| Inipharm | Nov 2020 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Ben Magnano
Managing Partner
Brian Morfitt
General Partner
J.P. Michael
General Partner - Structured Solutions
Nathan Every
General Partner
Philip Zaorski
Partner, General Partner
Lisa Robertson
Operating Partner
Michelle Ortner
Operating Partner (Advisory)
Anthony Draye
Partner, Technology & Innovation
Christina Reszka
Partner
Douglas Hollenbeck
Partner - Structured Solutions
Kent Berkley
Partner
Michael Miraflores
Partner, M&A
Ryan Lucero
Partner
Tanya Hayes
Partner, Human Capital & ESG - Center of Excellence
Vance Shen
Partner
Murphy Caine
COO & Partner, Head of Frazier s CoE Team
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Frazier Healthcare Partners based?
Frazier Healthcare Partners is headquartered in Seattle, Washington, United States.
When was Frazier Healthcare Partners founded?
Frazier Healthcare Partners was founded in 1991.
How many portfolio companies does Frazier Healthcare Partners have?
Frazier Healthcare Partners has 39 portfolio companies in Caplight's dataset.
What are some companies in Frazier Healthcare Partners's portfolio?
Portfolio companies visible on Caplight include pci pharma services, MBX Biosciences, Aclaris Therapeutics, Radionetics Oncology, Inipharm.
What was Frazier Healthcare Partners's most recent investment shown here?
Frazier Healthcare Partners's most recent investment in this portfolio sample was in Radionetics Oncology in 2021.
What sectors does Frazier Healthcare Partners focus on?
Frazier Healthcare Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Enterprise Software, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, FinTech, Frontier & Industrial Tech, Mobility, Transportation & Logistics.
What company stages does Frazier Healthcare Partners focus on?
Frazier Healthcare Partners typically invests at the MultiStage stage.
What is Frazier Healthcare Partners's AUM?
Frazier Healthcare Partners's assets under management are estimated between $1.0B and $10.0B.